Shandong Bailong Chuangyuan Stock Hits Day High with 7.36% Surge

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. has shown significant activity today, achieving a notable gain of 7.36% as of May 28, 2026. The stock reached an intraday high of CNY 25.49, reflecting a strong performance compared to the China Shanghai Composite, which only increased by 0.12% on the same day. In terms of financial metrics, Shandong Bailong has demonstrated resilience with a year-to-date performance of 16.85%, outperforming the broader market index. Over the past year, the company has generated an impressive return of 73.77%, alongside a 35% increase in profits. The company reported a robust operating cash flow of CNY 367.92 million and net sales of CNY 965.1 million, marking a growth rate of 17.89% over the last nine months. Despite some challenges in long-term growth, with a five-year performance decline of 41.84%, Shandong Bailong maintains an attractive valuation with a price-to-book ratio of 5.50 and a return on equity of 19.58%. The company continues to be a notable player in the FMCG sector, reflecting a mix of strong short-term gains and ongoing operational stability.